Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.
about
Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibilityChloroquine binding reveals flavin redox switch function of quinone reductase 2.A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer RelapsePolymorphism rs4919510:C>G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypesLow expression of stathmin in tumor predicts high response to neoadjuvant chemotherapy with docetaxel-containing regimens in locally advanced breast cancer.PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug.Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.Inverted low-copy repeats and genome instability--a genome-wide analysisNAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo.Clinical and genetic characterization of hereditary breast cancer in a Chinese population.Association of P53 gene polymorphism with gastric cancer in Northern Iran as a high-risk region.The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk.
P2860
Q21144942-6EC6BCA5-21FB-4655-9379-6C3BDBAB28F5Q34331796-B1A889ED-7D5E-4117-84DD-DB59CAA74E72Q35726685-5F6A21F7-D796-4B37-B39E-F53D40C7F52EQ35941705-65B36398-5A5A-41E0-913B-F3055FAD76D6Q36092750-2F61C0D6-7480-4FF3-8F08-8843FA80A115Q36393755-BA5778D6-E131-41F5-9498-AAB8868FEAA7Q36903253-F8ECC0E6-4768-4C8C-B290-5EE0BB5781FEQ37081586-F5711FFD-CD51-4816-8338-B51BADF65297Q37094626-3D7A4F51-7BAF-46CA-9832-8E74D6B78CE8Q39430809-A98DF66D-3DB9-4D6A-9035-3C5963174D22Q42253314-A4A68CDF-CCE0-4FFB-B131-A9EBB30041F0Q47095699-9D8C19F9-D95E-4171-93B0-CADEA09D501DQ52721807-4463CF2B-514A-4DB6-A642-DC63831326A1Q53295921-12455C1F-A1BC-44E1-A958-6F16B1579421
P2860
Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Functional polymorphisms, alte ...... ast cancer with wild-type p53.
@en
Functional polymorphisms, alte ...... ast cancer with wild-type p53.
@nl
type
label
Functional polymorphisms, alte ...... ast cancer with wild-type p53.
@en
Functional polymorphisms, alte ...... ast cancer with wild-type p53.
@nl
prefLabel
Functional polymorphisms, alte ...... ast cancer with wild-type p53.
@en
Functional polymorphisms, alte ...... ast cancer with wild-type p53.
@nl
P2093
P356
P1476
Functional polymorphisms, alte ...... ast cancer with wild-type p53.
@en
P2093
Gen-Hong Di
Wen-Tao Yuan
Ying Zheng
Zhen-Zhou Shen
Zhi-Ming Shao
P304
P356
10.1093/HMG/DDP171
P577
2009-04-07T00:00:00Z